课题基金 / 基金详情

项目摘要

项目成果

ALAN J HERR的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): As we age, our cells suffer a progressive and permanent loss of genetic information due to the accumulation of mutations. The mounting genetic deficits may limit cellular function or lead to cell death, thereby contributing to the loss of tissue homeostasis that occurs during aging. This proposal seeks to test the influence of mutation burden on aging of diploid yeast. We have evidence that excessive mutation rates can cause extinction of haploid yeast, due to random inactivation of essential genes. In Aim 1 we will define the upper limits of mutation burden for diploids. In Aim 2 we will transiently elevate mutation rates and then measure replicative lifespan, chronological aging, and competitive fitness in the presence and absence of oxidative damage and caloric restriction. In Aim 3, we will monitor cells for altered protein homeostasis as a possible consequence of mutation load. By these studies we hope to establish whether random mutation burden contributes to cellular aging and gain sufficient preliminary data to apply for an R01 to extend our studies into animals.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Volatility of mutator phenotypes at single cell resolution
  • 批准号:
    9295042
  • 项目类别:
  • 资助金额:
    $30.9万
  • 财政年份:
    2016
  • 负责人:
    ALAN J HERR
  • 依托单位:
Suppressors of Eukaryotic Mutator Phenotypes
  • 批准号:
    8444937
  • 项目类别:
  • 资助金额:
    $18.68万
  • 财政年份:
    2012
  • 负责人:
    ALAN J HERR
  • 依托单位:
Suppressors of Eukaryotic Mutator Phenotypes
  • 批准号:
    8581343
  • 项目类别:
  • 资助金额:
    $22.3万
  • 财政年份:
    2012
  • 负责人:
    ALAN J HERR
  • 依托单位:
Influence of Mutation Burden on Cellular Aging
  • 批准号:
    8190717
  • 项目类别:
  • 资助金额:
    $7.7万
  • 财政年份:
    2011
  • 负责人:
    ALAN J HERR
  • 依托单位:
国内基金
海外基金
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
  • 批准号:
    JCZRQN202500010
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
  • 依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
  • 批准号:
    2025JJ70209
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
    雷芬芳
  • 依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
  • 批准号:
    --
  • 项目类别:
    面上项目
  • 资助金额:
    --
  • 批准年份:
    2024
  • 负责人:
    万荣
  • 依托单位: